tiprankstipranks
Advertisement
Advertisement
Ardent: Solid Q1 Beat but Conservative 2026 Outlook Keeps Rating at Hold
PremiumRatingsArdent: Solid Q1 Beat but Conservative 2026 Outlook Keeps Rating at Hold
26d ago
Ardent: Solid Q1 and Reaffirmed 2026 Outlook Support Hold Rating as $12 Price Target Remains Unchanged
Premium
Ratings
Ardent: Solid Q1 and Reaffirmed 2026 Outlook Support Hold Rating as $12 Price Target Remains Unchanged
27d ago
Ardent Health price target lowered to $13 from $15 at Guggenheim
Premium
The Fly
Ardent Health price target lowered to $13 from $15 at Guggenheim
2M ago
Ardent Health Partners: Cost Efficiencies Balance Utilization Headwinds, Justifying a Hold Rating
PremiumRatingsArdent Health Partners: Cost Efficiencies Balance Utilization Headwinds, Justifying a Hold Rating
3M ago
Underperform Reiterated on Ardent: Aggressive EBITDA Targets and Reimbursement Risks Undermine Valuation
Premium
Ratings
Underperform Reiterated on Ardent: Aggressive EBITDA Targets and Reimbursement Risks Undermine Valuation
3M ago
Ardent Health reports Q4 EPS 32c, consensus 35c
Premium
The Fly
Ardent Health reports Q4 EPS 32c, consensus 35c
3M ago
Ardent Health Hit With Class Action Over Alleged Deceptions
PremiumClass ActionArdent Health Hit With Class Action Over Alleged Deceptions
5M ago
Ardent Health price target lowered to $14 from $14.50 at UBS
Premium
The Fly
Ardent Health price target lowered to $14 from $14.50 at UBS
6M ago
Ardent Health price target lowered to $12 from $20 at Mizuho
Premium
The Fly
Ardent Health price target lowered to $12 from $20 at Mizuho
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100